USPTO 2015–2025 USPTO PatentsView US Corporation

Cytonics Corporation

USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).

9
Total patents granted
10
CPC technology areas
18.6
Avg claims per patent
+25%
5-year filing velocity

The verdict

Cytonics holds 9 US patents across 10 technology areas, rank #28,519 of 50,000 tracked assignees.

#28,519
of 50,000 US assignees by volume
Top 62%
by Innovation Score (31.6/100)
18.6
avg claims per patent
+25%
filing velocity, last 5 yrs

Portfolio overview

Cytonics Corporation has been granted 9 US utility patents between 2016 and 2025, placing Cytonics Corporation at rank #28,519 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in C07K (PEPTIDES). As a US Corporation, Cytonics Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Cytonics sits between Cuesta Technology Holdings, Llc (9 patents, rank #28,515) and Dainippon Screen MFG. Co., Ltd. (9 patents, rank #28,523) - the closest US assignees by grant volume. The composite Innovation Score of 31.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cytonics Corporation's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cytonics Corporation against peers pursuing similar technology classes.

Who files at Cytonics's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cytonics holds 9 patents at rank #28,519, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cytonics

By rank, the assignees closest to #28,519 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Cytonics's primary technology class.

Cytonics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

32 Top 62% higher than 38% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20162019202120232025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Cytonics Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 22.2%
2019 2 22.2%
2021 3 33.3%
2023 1 11.1%
2025 1 11.1%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#28,519

Across all tracked assignees

Innovation Score

31.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cytonics Corporation hold?
Cytonics Corporation holds 9 US granted patents filed between 2016 and 2025, spanning 10 technology areas.
What is Cytonics Corporation's Innovation Score?
Cytonics Corporation has an Innovation Score of 31.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cytonics Corporation focus on?
Cytonics Corporation's top technology area is C07K (PEPTIDES) with 9 patents. The company has filed patents in 10 CPC subclasses total.
Is Cytonics Corporation's patent filing rate increasing or decreasing?
Cytonics Corporation's recent filing velocity is +25% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Cytonics Corporation's patents?
Cytonics Corporation's patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Cytonics Corporation patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cytonics's 9 grants land it in the top 62% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Cytonics ranks #28,519 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C07K - see who else leads that technology area. C07K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.